About Roche
Roche is a company based in Basel (Switzerland) founded in 1896. It operates as a HealthTech and Professional Services. The company has 103,250 employees as of December 31, 2024. Roche has completed 50 acquisitions, including 454 Life Sciences, Adheron Therapeutics and Anadys Pharma. Roche offers products and services including Pharma Solutions, Diagnostic Solutions, and Susvimo. Roche operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
- Headquarter Basel, Switzerland
- Employees 103250 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Roche Holding Ltd
-
Annual Revenue
$77.61 B (USD)1.69as on Dec 31, 2025
-
Net Profit
$16.25 B (USD)55.61as on Dec 31, 2025
-
EBITDA
$28.59 B (USD)4.59as on Dec 31, 2025
-
Latest Funding Round
Not available
-
Investors
SoftBank Group
& 4 more
-
Employee Count
103250
as on Dec 31, 2024
-
Investments & Acquisitions
454 Life Sciences
& 49 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Roche
Roche is a publicly listed company on the SIX with ticker symbol RO in Switzerland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Roche
Roche offers a comprehensive portfolio of products and services, including Pharma Solutions, Diagnostic Solutions, and Susvimo.
Innovative medicines are developed to treat various diseases.
Advanced diagnostic tools are provided for accurate disease detection.
Continuous delivery treatment is offered for diabetic macular edema.
People of Roche
Unlock access to complete
Unlock access to complete
Leadership Team
62 people
Software Development Team
54 people
Human Resources and Administration
40 people
Finance and Accounting
37 people
Operations Team
36 people
Product Management Team
31 people
Sales and Marketing
22 people
Senior Team
19 people
Unlock access to complete
Funding Insights of Roche
Investors in Roche
Roche has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include SoftBank Group, HHS and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provides financial advisory, investment planning, retirement services, and trust management for clients.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Investments are directed toward multiple sectors via fund of funds.
|
Locked | Locked | Locked |
Investor details for Roche
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Roche
Roche has strategically engaged in corporate development activities, having acquired 50 companies. Notable acquisitions include 454 Life Sciences, Adheron Therapeutics and Anadys Pharma.
Investment portfolio details for Roche
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapeutics for inflammatory and fibrotic diseases are developed.
|
Locked | Locked | 2022 | Locked | |
|
Provider of therapeutics related to oncology, autoimmune and metabolic disease
|
Locked | Locked | 2018 | Locked | |
|
Protein-based drugs for cancer treatment are developed.
|
Locked | Locked | 2016 | Locked |
Complete acquisition details for Roche
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Roche
Detailed financials for Roche
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Roche Comparisons
Peer comparison for Roche
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Roche
Roche operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
Detailed competitors of Roche
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Roche
Complete news archive for Roche
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Roche
Roche was founded in 1896 and raised its 1st funding round 108 years after it was founded.
Roche is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
Thomas Schinecker is the current CEO of Roche.
As of Dec 31, 2024, the latest employee count at Roche is 103,250.
Annual revenue of Roche is $77.61B as on Dec 31, 2025.
Roche is engaged in the development of innovative medicines and diagnostic solutions to improve health outcomes. The company operates in the healthcare sector, addressing urgent challenges through pharmaceuticals and diagnostics. Solutions are provided to prevent, stop, and cure diseases by identifying high-risk patients, accurately diagnosing conditions, and delivering targeted treatments. Efforts are directed toward revolutionizing patient care with technologies like Brainshuttle for CNS disease treatment.
Roche's top competitors include Merck, Roivant Sciences and AbbVie.
Roche offers Pharma Solutions, Diagnostic Solutions, and Susvimo.
Yes, Roche is publicly traded on SIX under the ticker symbol RO.
Roche has made 50 acquisitions, including 454 Life Sciences, Adheron Therapeutics, and Anadys Pharma.
Roche has 5 investors. Key investors include SoftBank Group, HHS, European Union, BAFA, and NHTrust.
The ticker symbol of Roche is RO on SIX.